comparemela.com

Latest Breaking News On - Paul kohlhaas - Page 1 : comparemela.com

A Guide to Decentralized Biotech

Shared lab space, DAO-funded projects, and other signs of big structural change in a traditionally centralized industry.

Charles-river
Massachusetts
United-states
Boston
Australia
Dallas
Texas
Australian
American
Celine-halioua
Paul-kohlhaas
Maggie-pearl

Pay for Success Contracts — A New Model to Develop New Therapies from Old Drugs | by Crowd Funded Cures | Sep, 2021

Pay for Success Contracts — A New Model to Develop New Therapies from Old Drugs | by Crowd Funded Cures | Sep, 2021
medium.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medium.com Daily Mail and Mail on Sunday newspapers.

Boston
Massachusetts
United-states
Australia
United-kingdom
University-college
New-south-wales
Australian
Ronnie-horesh
Steven-bigelsen
Andrew-horton
Vitalik-buterin

First biopharma IP-to-NFT transfer: Molecule and VitaDAO deploy Nevermined solution

First biopharma IP-to-NFT transfer: Molecule and VitaDAO deploy Nevermined solution
cointelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cointelegraph.com Daily Mail and Mail on Sunday newspapers.

Denmark
Copenhagen
Køavn
Switzerland
Danish
Ioana-ionescu
Aitor-argom
Paul-kohlhaas
University-of-copenhagen
Amazon-web-services
Danish-scheibye-knudsen-lab
Access-control

Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research

Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research
coinspeaker.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from coinspeaker.com Daily Mail and Mail on Sunday newspapers.

Denmark
Copenhagen
Køavn
Danish
Aitor-argom
Paul-kohlhaas
University-of-copenhagen
Danish-scheibye-knudsen-lab
Autonomous-organisation
Molecule-overcome-biopharma-industry
Legal-frameworks
Access-control

vimarsana © 2020. All Rights Reserved.